Skip to main content
. 2019 Jun 5;5(1):e000905. doi: 10.1136/rmdopen-2019-000905

Figure 2.

Figure 2

Survival without achieving remission, including vasculitis, asthma and ENT involvement remission. the median time to remission was 15 months in the ANCA positive group and 24 months in the ANCA negative group. Estimation was limited to the largest survival time evaluated (24 months after starting treatment), p=0.02 (log-rank test). ANCA, anti-neutrophil cytoplasmic antibodies; ENT, ear, nose and throat.